🚨Sponsored: Nemaura Medical Inc. (Nasdaq: NMRD)
Disclosure:
ZipTrader LLC is a publishing company, we are not financial advisors. This is not financial advice. Investments involve risk and are not guaranteed. Be sure to first consult with a qualified financial adviser and/or tax professional before implementing any strategy discussed herein. Past performance is not indicative of future performance. ZipTrader has been compensated twenty-five thousand USD by ACH Bank Transfer by Lifewater Media for YouTube advertising for Nemaura Medical Inc. (NMRD) on September 17, 2023. As of the date of this advertisement, the owners of ZipTrader do not hold a position in Nemaura Medical Inc. (NMRD). This advertisement and other marketing efforts may increase investor and market awareness, which may result in an increased number of shareholders owning and trading the securities of Nemaura Medical Inc. (NMRD), increased trading volume, and possibly an increased share price of Nemaura Medical Inc. (NMRD), which may or may not be temporary and decrease once the marketing arrangement has ended.
✅ZipTraderU: Get Our Morning Briefings, Step-by-Step Lessons, Trading Resources, Price Targets, Private Chat, & More ➤ http://goziptrader.com
📲GET EMAIL & SMS ALERTS ➤ https://ziptrader.com/sign-up (FREE)
🚀Join ZT Circle (Free) ➤ https://www.facebook.com/groups/ziptrader
💬 Charlie's Twitter ➤ http://twitter.com/zipcharlie
📝Trading Tutorials Playlist ➤ https://youtube.com/playlist?list=PLWCHyH3RlwTH1J1hn4OH5npnBV3icKPv-
📌New to the stock market and trading? We break everything down in a short sweet and simplified way.
Business & ZipTrader Support Inquiries charlie @ziptraders.com
Time Stamps:
0:00 INTRO
1:13 REASON #1
2:26 REASON #2
6:17 THE MATH
11:07 NEW IDEA!
#notfinancialadvice #tesla #teslastock
⚠️Terms of Service & Disclaimer:
BY USING ZIPTRADER & ALL CONTENT YOU AGREE: This is not financial advice. You must do your own due diligence on all information. ZipTrader LLC is a publishing company and we provide general information, opinions, & news coverage to viewers. However – we do not provide personalized financial advice, are not financial advisors, and our opinions are not suitable for all investors. You should not treat any opinion as expressed as a specific inducement to make a particular investment or follow a particular strategy, but just as an opinion. Use at your own risk.
TRADING IS RISKY, PREPARE TO LOSE 100%+ OF YOUR MONEY: Most traders in all markets lose all of their money (and more if they use margin). Most small businesses fail. Do NOT partake in trading, investing, entrepreneurship or any other risky endeavor covered in this content if you are not prepared with the reality that most fail.
Past Performance is not indicative of future results, and any results presented are not typical, and should not be understood as typical. We oftentimes discuss or show hypothetical returns as case studies for educational demonstration and news coverage – but these do not represent actual results. Actual results vary given a variety of factors such as experience, skill, risk mitigation practices, market dynamics, execution and the amount of capital deployed.
AFFILIATE DISCLOSURE: Some of the links on this webpage are affiliate links, meaning, at no additional cost to you, I may earn a commission if you click through and make a purchase and/or subscribe.
Full Terms of Service - https://ziptrader.com/termsofservice/
Disclosure:
ZipTrader LLC is a publishing company, we are not financial advisors. This is not financial advice. Investments involve risk and are not guaranteed. Be sure to first consult with a qualified financial adviser and/or tax professional before implementing any strategy discussed herein. Past performance is not indicative of future performance. ZipTrader has been compensated twenty-five thousand USD by ACH Bank Transfer by Lifewater Media for YouTube advertising for Nemaura Medical Inc. (NMRD) on September 17, 2023. As of the date of this advertisement, the owners of ZipTrader do not hold a position in Nemaura Medical Inc. (NMRD). This advertisement and other marketing efforts may increase investor and market awareness, which may result in an increased number of shareholders owning and trading the securities of Nemaura Medical Inc. (NMRD), increased trading volume, and possibly an increased share price of Nemaura Medical Inc. (NMRD), which may or may not be temporary and decrease once the marketing arrangement has ended.
✅ZipTraderU: Get Our Morning Briefings, Step-by-Step Lessons, Trading Resources, Price Targets, Private Chat, & More ➤ http://goziptrader.com
📲GET EMAIL & SMS ALERTS ➤ https://ziptrader.com/sign-up (FREE)
🚀Join ZT Circle (Free) ➤ https://www.facebook.com/groups/ziptrader
💬 Charlie's Twitter ➤ http://twitter.com/zipcharlie
📝Trading Tutorials Playlist ➤ https://youtube.com/playlist?list=PLWCHyH3RlwTH1J1hn4OH5npnBV3icKPv-
📌New to the stock market and trading? We break everything down in a short sweet and simplified way.
Business & ZipTrader Support Inquiries charlie @ziptraders.com
Time Stamps:
0:00 INTRO
1:13 REASON #1
2:26 REASON #2
6:17 THE MATH
11:07 NEW IDEA!
#notfinancialadvice #tesla #teslastock
⚠️Terms of Service & Disclaimer:
BY USING ZIPTRADER & ALL CONTENT YOU AGREE: This is not financial advice. You must do your own due diligence on all information. ZipTrader LLC is a publishing company and we provide general information, opinions, & news coverage to viewers. However – we do not provide personalized financial advice, are not financial advisors, and our opinions are not suitable for all investors. You should not treat any opinion as expressed as a specific inducement to make a particular investment or follow a particular strategy, but just as an opinion. Use at your own risk.
TRADING IS RISKY, PREPARE TO LOSE 100%+ OF YOUR MONEY: Most traders in all markets lose all of their money (and more if they use margin). Most small businesses fail. Do NOT partake in trading, investing, entrepreneurship or any other risky endeavor covered in this content if you are not prepared with the reality that most fail.
Past Performance is not indicative of future results, and any results presented are not typical, and should not be understood as typical. We oftentimes discuss or show hypothetical returns as case studies for educational demonstration and news coverage – but these do not represent actual results. Actual results vary given a variety of factors such as experience, skill, risk mitigation practices, market dynamics, execution and the amount of capital deployed.
AFFILIATE DISCLOSURE: Some of the links on this webpage are affiliate links, meaning, at no additional cost to you, I may earn a commission if you click through and make a purchase and/or subscribe.
Full Terms of Service - https://ziptrader.com/termsofservice/
Folks in today's video: I'm going to make the case for Tesla to get to one thousand dollars per share I'm going to explain the individual reasons why Tesla will continue to outperform and then I'm going to break down the actual math I'm going to break out a violent spreadsheet and explain to you how the underlying business will justify this one thousand dollars a share valuation. This will be a unique video with some insights that I guarantee you haven't heard before. and I highly recommend watching to the very end of this video. and then lastly, we're going to cover today's sponsored stock and Mrd for Namara Medical Inc And Mrd is a NASDAQ trading super small cap in the med tech space that is developing and commercializing wearable diagnostic devices and most importantly, a non-invasive blood glucose monitoring system for people with diabetes and perhaps even for screening pre-diabetic patients.
Diabetes of course is a huge market and any company that can offer blood glucose monitoring without having to go and prick your finger, well, likely it's going to be super competitive. The company also just got upgraded to abide by Zach's investment research. I'll break down what this company is doing and why you may want to check out the setup as soon as possible and begin your due diligence. Let's get to work timestamps down below.
Okay, let's go ahead and start. So the first reason that Tesla will hit one thousand dollars a share is because number One EV sales overall are expected to grow by a compounding annual growth rate of 24.5 percent by 2030 and Tesla will be by far the biggest benefactor of that you see. Tesla right now controls 59.5 percent of new EV registrations by Brandt 59.5 And this market share is actually increasing as Tesla has started competing on price by dropping prices of their most popular models. This is from Reuters buoyed by Hefty discounts Tesla share of China's electric vehicle Market almost doubled in August to 13.2 percent from 7.5 percent in July.
A lot of people like to say no Tesla has been destroyed completely destroyed by Chevrolet by Ford and so on and so forth, but same ad is really just a sad joke. It is simply not the case. Chevrolet is the second biggest player and it's at around one tenth one-tenth the market share of Tesla. And again, Tesla's dominance is growing as the company finally starts competing on price.
They not only have a massive Head Start in terms of the overall technology, but they also have very, very, very big brand recognition and and have the trust and the reliability of a company that's been doing EVS for 10 plus years. Second reason for Tesla at one thousand dollars per share, the autonomous vehicle Market The autonomous vehicle Market is going to be a huge huge Money Maker for Tesla while the electric vehicle Market has a 24.5 percent kagger expected over the coming years, while the autonomous vehicle Market is expected to grow at a rate of 35 percent. Now, it is true. certainly that other autonomous vehicle manufacturers or rather software companies do have in some cases better technology better software than Tesla does currently, but there's no guarantee that's going to continue. and quite frankly, it doesn't even matter if you look at the overall picture. Tesla is destroying the game. Tesla is going to lead an autonomous driving because electric vehicles are going to be the status quo of new car sales 10 years from now and Tesla will be the market leader in that, and likely we'll continue not to have much competition. You'll have a lot of people offering EVS, but none that have the sort of Market penetration that Tesla will have.
And as the EV Market expands to cover more and more of the overall car market, it's only about five percent right now. Once that expands to be 30, 40, 50. Well, all of a sudden, Tesla the percentage of new cars that are sold by Tesla is going to go up a lot and all of those are only going to be compatible with of course, Tesla's autonomous driving system. so that's a huge Advantage right out of the gate.
Tesla is also going to have the advantage in terms of name recognition. When people think autonomous driving, they think Tesla more than anything else and that is not going to change. Tesla also has the advantage of having significantly more data points to use. The more data you have with self-driving the better.
Tesla already has a massive Fleet of many, many, many, many hundreds of thousands of vehicles using earlier versions of autonomous driving. which means that Tesla has had an exponential ability to learn and improve over many years. But if you're not buying those arguments, well, most importantly, you have to think about Tesla's super computer. Dojo Tesla's super Computing technology is going to be nearly impossible to compete with.
Morgan Stanley Analysts highlighted the importance of this a couple weeks ago and it led to a lot more people paying attention to the stock. The Supercomputer essentially processes the insane amount of data points that self-driving technology that is being employed every day by Tesla's on the road take in. and it uses those data points to come out and train the software to be better and better and better. So whatever company has more data points and the ability to process it the fastest is going to win.
And Tesla is really, really, really, really leading the race In this, There's a lot of companies that do well in one mileage, driven, or in processing power, but few do well in both of them. Quite frankly, the company with the best of both is going to win the game Tesla is projecting. It will be in the top five for computing power by early 2024, and likely be the king short after. And here's the thing folks: the autonomous vehicle boom and the demand for autonomous technology software is not only going to allow Tesla to sell a lot more cars, but more importantly, we'll allow Tesla to sell super high margin software AI Autonomous Vehicle Driving software to tons of companies jumping for an opportunity to make their own. Vehicles Autonomous without having to spend billions and billions of dollars and years to develop their own. So this is when Tesla's going to be really, really shining as a software company. So you have insane Revenue generating opportunities from the hardware side and then insane insane Revenue generating opportunities from the software side. But of course, software tends to be a lot higher margin than Hardware right? Once you've built a great software, all of a sudden, that profit margin starts going up a lot.
Other catalysts for Tesla include the Cyber truck, which is going to start production this year and based on pre-order numbers, can produce around 96 to 150 billion dollars worth of Revenue alone. Tesla's also expected to introduce even lower priced math production models which can drive significant revenue and subscription income. Tesla's also working on semis with up to 500 million in range that go 0 to 60 in 20 seconds, which is pretty damn fast for a semi truck. All of these can serve as very powerful catalysts to drive revenue and money to Tesla's bottom line in the coming years.
But let's go ahead and talk about the math and break out the violent violent spreadsheet. So for full year 2023, total revenue is likely going to be around 100 to 105 billion dollars, give or take. Last year was around 80 billion. We'll call it at 105 billion since the pricing war is going pretty well.
Could be a little bit more than that, but we'll say 105 billion car sales are likely going to be at about 85 percent of that at 89 billion, energy storage around 6.2 billion, software subscriptions and others are at around 9.8 billion. Now, at the same time, you're sitting at about 274 dollars, a share market cap at 859.79 million, and a price to sales multiple at 8.18 So that is the current setup you're looking at. Now let me tell you what the math suggests that the numbers are going to scale up to. Let's say it's 20, 30 and Tesla lost substantial market share, but still controls about 40 percent of the electrical vehicle.
Market Well, that's projected to be a 1.335 trillion dollar market, so that comes out to 534 billion in Revenue intake for Tesla and let's say that Tesla controls 25 percent of the autonomous vehicle Market which is projected to be a 1.227 trillion dollar a year Market Well, that comes out to be just under 307 billion in Revenue Intake Energy storage is also supposed to go up some 8.4 percent according to Precedence research, so we'll add that in there too assuming Tesla goes up the average pace at the industry. Maybe that's under shooting it or not, but still look at the bigger picture here. We'll say that becomes about a 10 billion dollar a year business for Tesla and we'll say that Misc Revenue goes up from 9.8 billion in 2023 and grows out a rate of like five percent a year. Just to keep it simple, and we'll say that's a 13.1 billion dollar business again at the end of the day. These are kind of rounding errors I'm just putting them in here to be proper. but I think that those growth rates are reasonable. But what do you get when you have this all together? Charlie Charlie Well, you get 863 billion, 850 million in Revenue in 2030.. Now remember that these numbers assume that Tesla's market share and the EV sales pie went from about 60 to 40, so that's a substantial drop.
And at the same time it assumes that they only get about 25 percent of the autonomous vehicle market share. Pretty big concessions here, right? Yep, But let's go ahead and make another concession and say that Tesla's multiple gets cut down to five from this year's 8.18 Well, that then puts us at a market cap of 4.319 trillion bucks. So what is the share price of that market cap? Well, if shares outstanding are at say 4 billion, well, you're sitting at a Tesla price of 1079 in 2030.. Now when you're talking multiples, you always got to remember that you do have to make some assumptions: multiples can be very, very different depending on the market condition, how people are factoring in future earnings and future Revenue to your stock and so on and so forth.
If an environment is really, really conducive, five might be nothing. This could be trading at 8, 9, 10, 15 multiple. If it's not so conducive, perhaps it's at four or three. But bigger picture in an Ever rotated Market is that Tesla easily easily justifies a 1 000 per share a little bit more at 1079 per share valuation in 2030..
Now the next question is: when is it actually going to hit that? I'm talking about when it's going to justify it. When is it actually going to hit this thousand dollars per share? Could it happen earlier? Could it happen in 2028, 2026? 2025? Well, certainly. It Could Happen a lot earlier. And in order to understand that, you got to understand how multiples have worked historically for Tesla stock, it's all about Tesla showing proof of concept, beating haters, and also very, very importantly, lower interest rate.
Very, very easy monetary policy in January 2021, for example, Tesla traded at a sales multiple of 30. Now, will a multiple of 30 ever happen again? probably not. But if it did, you'd only have to have 144 billion in Revenue to hit that one thousand dollar a share price 144 billion in Revenue Tesla could easily do by 2025 2026 at the latest. But what about if Tesla traded at a 10 multiple? well, they'd have to have 430 billion in Revenue Again, not something that's that far away for Tesla A few years, if it could trade at a multiple of 15, it would only need 280 billion in Revenue.
If it could trade in a multiple of 20, it would only need 215 billion in Revenue. So again, you could see that it's not just oh, the company is producing insane amounts of Revenue but it's also the multiple that is being paid on that Revenue Which a whole multitude of factors goes into that. There's also that Dynamic where if Tesla starts shooting out, just completely shooting out profits because of the software growth, well, all of a sudden earnings are going to be a much bigger driver for Tesla stock and the multiple on sales might be able to expand quite a lot more. So bigger picture here Again, multiples have a big say in this, but for forecasting purposes, it's reasonable to say that 10 Tesla in 2030 will easily easily justify a one thousand dollar per share price Target but at the same time probably will hit a thousand dollars per share way before that, Let us know what you think about Tesla Stock down below. Is it going to be able to hit the numbers we've laid out in this video? Or is it going to be a lot more of a rough time? Let us know down below. Okay, now it's time to move on to today's sponsored stock and that is Nmrd for Namora. Medical Inc And Mrd is a NASDAQ trading super small cap in the med tech space that is developing and commercializing wearable diagnostic devices and most importantly, a non-invasive blood glucose monitoring system for people with diabetes and perhaps even for screening pre-diabetic patients. Diabetes is, of course, a huge market, and this could be a very, very lucrative, lucrative medical device for this company.
If they can successfully get it to Market we're going to break down everything you need to know and why you may want to start your due diligence on the stock as soon as possible. Okay folks, so here's the deal. According to Forbes over 11 percent of the US population is known to be diabetic. That's some 37.3 million people.
There's another 60 million plus people over in Europe And the standard of care for these folks is the minimally invasive but still invasive traditional finger prick, which quite frankly, I've had some family members that are diabetic and it's a pretty big annoyance. So of course there's been a big rush to replace this with something that isn't invasive where you don't have to actually go and prick your finger and get that blood out. And that's the market that Namara is trying to solve for. They offer wearable diagnostic devices now.
why would somebody want to go through the trouble? the discomfort, and the pain of pricking your finger throughout the day when you can just have a wearable device on your wrist that monitors it for you without ever having to break your finger. So that's why this Tech is so interesting, right? It's obvious to me at least that that would be a big, big winner. and Nomura's business model is such that it could generate revenue and not just product sales, but also ongoing subscriptions for the software that comes with monitoring these glucose levels. But Charlie Aren't there other companies trying to do this? well? Certainly, But Nmrd has the first mover. Advantage An Mrd Sugar Beet is known as the world's first non-invasive Glucose monitor. Sugar beet is an approved class 2B medical device. in Europe it's FDA PMA The pre-market approval has been submitted and is in review and frequently in the FDA game. Being earlier in the process usually means being earlier to get to Market and that could mean that Nmrd has a big time advantage over its competitors.
Let's talk future targets and potential catalysts: Number one: Obtaining FDA approval for sugarbeet that would of course be a very, very big deal for the stock. Number two: scaling up manufacturing to support sales in the UK Europe and the Middle East Number three building market share in the USA with employers and insurers. and and those are the three catalysts that you want to put on your radar If you're somebody that thinks this is a stock worth following which I think you should be someone like that Now Zach's investment research which quite frankly gets a ton of viewership. Just upgraded and Mrd they said quote Nomura Medical Inc and Mrd could be a solid addition to your portfolio given its recent upgrade to a Zax rank number two: Buy A Buy alert an upward Trend in earnings estimates one of the most powerful forces impact back in stock prices has triggered this rating change.
Okay, but let's go ahead and move over to the Chart setup. We Love featuring companies in Biotech that are working on real solutions that make people's lives better. But this is still a finance and trading channel, so it's all about if this actually has some room to run. And when you're talking about Biotech small caps, quite frankly, you're talking about companies that are taking big risks to potentially get big rewards.
and if they fail, they drop dramatically. And so there's a lot of fear and hype Cycles going back and forth during the development phase as investors try to factor in the risk of complete success and the risk of complete failure. There's huge cycles of fear and hype that go back and forth along the development phases. But the thing with Nmrd is right now we are trading around one-third of where we were in July and we are down about 88 percent from where we were at highs in January of this year.
These are insanely fearful prices and that means that if Nmrd does continue to build its business and does continue to get more eyeballs as it moves through the stages, well, you could see the stock have and realize significant more upside. But from our perspective as Traders here the main key is asking, is there an Arbitrage opportunity in all the sphere and my thought process is you should go and do your own due diligence on the stock and the company and ask yourself what kind of money this product can make if it gets through all of these stages and if it gets to that final stage of getting to Market it also asks what is the risk if it doesn't go through. We get a lot of offers from sponsorship stocks in the sponsorship stock segment, but the reason that I took this one today is because I believe that the risks were over factored in here and the rewards were really really under factored in. Look at the previous chart and ask yourself Okay, well now that we're at year-to-date lows, basically year-to-date lows, Well, is that justified or could you very easily see that bounce back to much higher levels? Is the risk overfactured in here? Is the potential under factored in? These are things to ask yourself and thanks to do your due diligence on. Anyways, folks that caps off today's video make sure to hit that rap if you like button and subscribe if you found value in it and we'll see you in the next one.